Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Gains from Sales and Divestitures (2019 - 2025)

Tvardi Therapeutics' Gains from Sales and Divestitures history spans 7 years, with the latest figure at $792.0 for Q1 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 37.83% to $792.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $792.0, a 37.83% decrease, with the full-year FY2024 number at $31170.0, changed N/A from a year prior.
  • Gains from Sales and Divestitures hit $792.0 in Q1 2025 for Tvardi Therapeutics, down from $31170.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for TVRD hit a ceiling of $357060.0 in Q2 2024 and a floor of $792.0 in Q1 2025.
  • Historically, Gains from Sales and Divestitures has averaged $62390.8 across 5 years, with a median of $17333.0 in 2022.
  • Biggest five-year swings in Gains from Sales and Divestitures: surged 1310.18% in 2023 and later tumbled 98.48% in 2024.
  • Tracing TVRD's Gains from Sales and Divestitures over 5 years: stood at $215000.0 in 2021, then crashed by 97.05% to $6341.0 in 2022, then skyrocketed by 1221.45% to $83793.0 in 2023, then tumbled by 62.8% to $31170.0 in 2024, then tumbled by 97.46% to $792.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for TVRD at $792.0 in Q1 2025, $31170.0 in Q4 2024, and $8875.0 in Q3 2024.